시장보고서
상품코드
2008800

일회용 바이오프로세싱 시장 보고서 : 제품 유형별, 용도별, 최종 용도별, 최종사용자별, 지역별(2026-2034년)

Single-Use Bioprocessing Market Report by Product Type, Application, End-Use, End-User, and Region 2026-2034

발행일: | 리서치사: 구분자 IMARC | 페이지 정보: 영문 139 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트 등의 Copy&Paste도 불가능합니다.
US $ 3,999 금액 안내 화살표 ₩ 5,886,000
PDF & Excel (5 User License) help
PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,999 금액 안내 화살표 ₩ 7,359,000
PDF & Excel (Corporate License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 가능합니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,999 금액 안내 화살표 ₩ 8,831,000
카드담기
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 일회용 바이오프로세싱 시장 규모는 2025년에 215억 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 736억 달러에 달하며, 2026-2034년에 CAGR 14.18%로 성장할 것으로 예측하고 있습니다. 만성질환의 증가, 기술 발전, 의약품 및 생물제제 승인 건수 증가는 시장을 촉진하는 주요 요인 중 일부입니다.

일회용 바이오 프로세싱 기술은 바이오의약품의 여과, 보존, 세포배양, 혼합 및 정제를 한 번만 사용하도록 설계되었습니다. 이 기술은 비용 효율적이고, 시간을 절약할 수 있으며, 유연하고 번거롭지 않은 폐기 처리가 가능합니다. 기존 바이오 프로세싱에 비해 복잡한 공정을 제거하여 생산성 향상에 기여하고, 개체 간 교차 오염 위험을 줄입니다. 또한 철강 설비와 비교하여 에너지 및 매체 소비, 탄소발자국을 줄이고 지속가능한 제조 공정을 실현할 수 있다는 점에서도 이점이 있습니다. 이 기술은 백신, 식물 세포배양, 단클론 항체의 효율적인 생산에 활용되고 있습니다. 또한 설정, 검증, 문서화에 소요되는 직원들의 시간을 단축할 수 있으며, 일회용 바이오프로세싱 기술에 대한 수요가 전 세계에서 증가하고 있습니다.

일회용 바이오프로세싱 시장 동향:

현재 전 세계에서 당뇨병, 천식, 관절염, 암, 고혈압, 심근경색, 뇌졸중, 만성폐쇄성폐질환(COPD) 등 만성질환의 유병률이 증가하고 있는 것이 시장 성장을 이끄는 주요 요인 중 하나입니다. 이와 더불어, 전 세계에서 의약품 승인 및 생물제제의 수가 증가함에 따라 일회용 바이오 프로세싱에 대한 수요가 증가함에 따라 시장에 긍정적인 영향을 미치고 있습니다. 또한 고강도의 고품질 폴리머 소재와 플라스틱 복합재로 제조된 제품에 대한 선호도가 높아짐에 따라 업계 투자자들에게 매력적인 성장 기회를 제공하고 있습니다. 이 외에도 인력, 자재, 투자 비용 절감 등 일회용 바이오 프로세싱 시스템이 제공하는 다양한 이점이 시장 성장을 촉진하고 있습니다. 이와 더불어, 오류를 예측하고 정확도를 높이기 위해 일회용 바이오프로세싱 분야에서 인공지능(AI), 머신러닝(ML), 빅데이터 솔루션 등 다양한 기술 발전이 등장하면서 시장 성장을 촉진하고 있습니다. 또한 의약품 제조의 배지 제조 및 바이오의약품 운송에 있으며, 일회용 바이오 프로세싱의 사용이 확대되고 있는 것도 시장에 긍정적인 전망을 가져다주고 있습니다. 이에 따라 기존 바이오프로세스에 비해 이산화탄소(CO2) 배출량을 줄일 수 있다는 점에서 일회용 바이오 프로세싱의 채택이 확대되고 있으며, 이는 시장 성장을 촉진하고 있습니다. 또한 전 세계 의료 시설의 개선이 진행됨에 따라 일회용 바이오프로세싱의 이용이 증가하고 있으며, 이 또한 시장 성장에 기여하고 있습니다.

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 개요

제4장 서론

제5장 세계의 일회용 바이오프로세싱 시장

제6장 시장 내역 : 제품 유형별

제7장 시장 내역 : 용도별

제8장 시장 내역 : 최종 용도별

제9장 시장 내역 : 최종사용자별

제10장 시장 내역 : 지역별

제11장 SWOT 분석

제12장 밸류체인 분석

제13장 Porter's Five Forces 분석

제14장 경쟁 구도

KSA 26.05.07

The global single-use bioprocessing market size reached USD 21.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 73.6 Billion by 2034, exhibiting a growth rate (CAGR) of 14.18% during 2026-2034. The growing prevalence of chronic diseases, increasing technological advancements, and rising number of drug approvals and biologics represent some of the key factors driving the market.

Single-use bioprocessing technology is designed for filtration, storage, cell culture, mixing, and purification of biopharmaceutical products for one-time use. It is cost-effective, timesaving, and provides flexibility and hassle-free disposal. It assists in increasing productivity by eliminating complex steps and reduces the risks of cross-contamination among individuals as compared to traditional bioprocessing. Besides this, it is beneficial in reducing energy, media consumption, and carbon footprint and providing a sustainable manufacturing process as compared to steel. It is utilized for the effective production of vaccines, plant cell cultivation, and monoclonal antibodies. As it also reduces the time of staff members for set-up, validation, and documentation, the demand for single-use bioprocessing technology is increasing across the globe.

SINGLE-USE BIOPROCESSING MARKET TRENDS:

Presently, the rising prevalence of chronic diseases, such as diabetes, asthma, arthritis, cancer, hypertension, heart attack, stroke, and chronic obstructive pulmonary disease (COPD), among the masses across the globe represents one of the key factors supporting the growth of the market. Apart from this, the growing demand for single-use bioprocessing due to the increasing number of drug approvals and biologics around the world is positively influencing the market. Additionally, rising preferences of products manufactured from high-grade polymer materials and plastic composites, as they offer enhanced integral strength, is offering lucrative growth opportunities to industry investors. Besides this, various benefits offered by single-use bioprocessing systems, such as lower labor, material, and investment costs, are propelling the growth of the market. In addition to this, the emergence of various technological advancements, such as artificial intelligence (AI), machine learning (ML), and big data solutions in single-use bioprocessing for predicting errors and improving accuracy, is bolstering the growth of the market. Moreover, the growing utilization of single-use bioprocessing in media preparation and shipping of biologics while manufacturing pharmaceuticals is offering a favorable market outlook. In line with this, the rising adoption of single-use bioprocessing, as it reduces the amount of carbon dioxide (CO 2 ) compared to traditional bioprocessing, is impelling the growth of the market. Furthermore, the increasing employment of single-use bioprocessing due to the improving healthcare facilities across the globe is contributing to the growth of the market.

KEY MARKET SEGMENTATION :

Product Type Insights:

  • Media Bags and Containers
  • Filtration Assemblies
  • Single-Use Bioreactors
  • Disposable Mixers
  • Others

Application Insights:

  • Filtration
  • Storage
  • Cell Culture
  • Mixing
  • Purification

End-Use Insights:

  • Upstream
  • Fermentation
  • Downstream

End-User Insights:

  • Biopharmaceutical Manufacturers
  • Life Science R&D
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • Iran
    • United Arab Emirates
    • Others

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, and others); and the Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, and others). According to the report, North America (the United States and Canada) was the largest market for single-use bioprocessing. Some of the factors driving the North America single-use bioprocessing market included the presence of large-scale manufacturing units, rising geriatric population, increasing healthcare expenditure, etc.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global single-use bioprocessing market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc., 3M Company, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the global single-use bioprocessing market?

2. What is the expected growth rate of the global single-use bioprocessing market during 2026-2034?

3. What are the key factors driving the global single-use bioprocessing market?

4. What has been the impact of COVID-19 on the global single-use bioprocessing market?

5. What is the breakup of the global single-use bioprocessing market based on the product type?

6. What is the breakup of the global single-use bioprocessing market based on the application?

7. What is the breakup of the global single-use bioprocessing market based on the end-use?

8. What is the breakup of the global single-use bioprocessing market based on the end-user?

9. What are the key regions in the global single-use bioprocessing market?

10. Who are the key players/companies in the global single-use bioprocessing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Single-Use Bioprocessing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Media Bags and Containers
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Filtration Assemblies
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Single-Use Bioreactors
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Disposable Mixers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Filtration
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Storage
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cell Culture
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Mixing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Purification
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End-Use

  • 8.1 Upstream
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fermentation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Downstream
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Biopharmaceutical Manufacturers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Life Science R&D
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Argentina
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
    • 10.4.4 Colombia
      • 10.4.4.1 Market Trends
      • 10.4.4.2 Market Forecast
    • 10.4.5 Chile
      • 10.4.5.1 Market Trends
      • 10.4.5.2 Market Forecast
    • 10.4.6 Peru
      • 10.4.6.1 Market Trends
      • 10.4.6.2 Market Forecast
    • 10.4.7 Others
      • 10.4.7.1 Market Trends
      • 10.4.7.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Turkey
      • 10.5.1.1 Market Trends
      • 10.5.1.2 Market Forecast
    • 10.5.2 Saudi Arabia
      • 10.5.2.1 Market Trends
      • 10.5.2.2 Market Forecast
    • 10.5.3 Iran
      • 10.5.3.1 Market Trends
      • 10.5.3.2 Market Forecast
    • 10.5.4 United Arab Emirates
      • 10.5.4.1 Market Trends
      • 10.5.4.2 Market Forecast
    • 10.5.5 Others
      • 10.5.5.1 Market Trends
      • 10.5.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Applikon Biotechnology
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Boehringer Ingelheim
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cesco Bioengineering Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Corning Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Entegris
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Eppendorf AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Finesse Solutions Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 GE Healthcare
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Infors
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Merck Millipore
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Rentschler Biotechnologie
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Sartorius Stedim Biotech
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
    • 14.3.14 Thermo Fisher Scientific Inc.
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials
      • 14.3.14.4 SWOT Analysis
    • 14.3.15 3M Company
      • 14.3.15.1 Company Overview
      • 14.3.15.2 Product Portfolio
      • 14.3.15.3 Financials
      • 14.3.15.4 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기